Taurine-Supplemented Cell Culture Medium for Protein Yield

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing cell culture media for recombinant protein production face challenges in optimizing productivity and minimizing toxic byproducts like ammonia, particularly in taurine-supplemented cultures, leading to suboptimal growth and yield of biopharmaceuticals.

Innovation Solution

Incorporation of taurine into a serum-free cell culture medium at concentrations ranging from 0.1 mM to 10 mM, along with specific amino acids, fatty acids, nucleosides, and salts, enhances cellular productivity and reduces ammonia byproducts.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional cell culture media are used for recombinant protein production, then basic cell growth is maintained, but productivity and yield of biopharmaceuticals are suboptimal

Engineering Contradiction:
Improverecombinant protein productivityVSAvoidyield consistency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by supplementing the cell culture medium with taurine at optimized concentrations (0.1-10 mM). This chemical parameter modification enhances cellular productivity and reduces ammonia byproducts, directly improving recombinant protein yield and consistency without changing the fundamental culture system

Inventive Principle:
Principle #35Parameter changes

2Productivity

If amino acid supplementation is increased to boost cell growth, then continuous cell growth is enhanced, but accumulation of toxic byproducts such as ammonia increases

Engineering Contradiction:
Improvecell growth rateVSAvoidammonia byproduct accumulation
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful effect of ammonia accumulation into a beneficial outcome by adding taurine supplementation. Taurine modifies cellular metabolism to reduce ammonia production while maintaining high cell growth rates, effectively turning a toxic byproduct problem into an optimized growth condition

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Productivity

If feeding strategies are optimized to maximize protein expression, then productivity increases, but the complexity of managing multiple amino acids and timing of addition increases

Engineering Contradiction:
Improveprotein expression yieldVSAvoidfeeding strategy complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent extracts and isolates the key beneficial component (taurine) from complex amino acid mixtures. By focusing supplementation on taurine alone at 0.1-10 mM, the patent simplifies the feeding strategy while maintaining high protein expression yields, eliminating the need to manage multiple amino acid additions and timing schedules

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS20250327023A1Taurine supplemented cell culture medium and methods of use
Publication Date: 2025.10.23 REGENERON PHARMACEUTICALS INC
  • US20250327023A1 patent drawing
  • US20250327023A1 patent drawing

AI summary

The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.